Electrochemical Studies of Camptothecin and Its Interaction with Human Serum Albumin

Other literature type, Article English OPEN
Genxi Li; Junyi Huang; Wei Xing; Xiaofeng Zheng; Jing Zhao;
(2007)
  • Publisher: MDPI AG
  • Journal: International Journal of Molecular Sciences,volume 8,issue 1,pages42-50 (issn: 1422-0067, eissn: 1422-0067)
  • Related identifiers: doi: 10.3390/i8010042, pmc: PMC3662986
  • Subject: Chemistry | QD1-999 | QH301-705.5 | Camptothecin | cyclic voltammetry | human serum albumin | Articles | Biology (General)
    mesheuropmc: biological phenomena, cell phenomena, and immunity | body regions | embryonic structures | polycyclic compounds | heterocyclic compounds

Camptothecin, an anticancer component from Camptotheca acuminate, may interact with human serum albumin (HSA) at the subdomain IIA (site I), and then convert to its inactive form(carboxylate form). In this paper, the detailed electrochemical behaviors of camptothecin at... View more
  • References (23)
    23 references, page 1 of 3

    1. Marco, E.; Laine, W.; Tardy, C.; Lansiaux, A.; Iwao, M.; Ishibashi, F.; Bailly, C.; Gago, F. Molecular Determinants of Topoisomerase I Poisoning by Lamellarins: Comparison with Camptothecin and Structure-Activity Relationships. J. Med. Chem. 2005, 48, 3796-3807.

    2. David A. Litvak; Harry T. Papaconstantinou; B. Mark Evers; Courtney M. Townsend, Jr. Targeting molecular pathways with camptothecin as novel therapy for gastric cancer. Journal of Gastrointestinal Surgery 1999, 3, 618-624.

    3. Liu W.M; Zhang R.W. Upregulation of p21 (WAF1/CIP1) in human breast cancer cell lines MCF7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10- hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. International Jounal Of Oncology 1998, 12 (4), 793-804.

    4. Sanchez-Alcazar JA; Bradbury DA; Brea-Calvo G; Navas P; Knox AJ Camptothecin-induced apoptosis in non-small cell lung cancer is independent of cyclooxygenase expression. Apoptosis 2003, 8 (6), 639-647.

    5. Heyong Gao; Xiongwen Zhang; Yi Chen; Hongwu Shen; Tao Pang; Jing Sun; Chenghui Xu; Jian Ding; Chuan Li; Wei Lu Synthesis and antitumor activity of the hexacyclic camptothecin derivatives. Bioorganic & Medicinal Chemistry Letters 2005, 15, 3233-3236.

    6. Hertzberg, R.P.; Busby, R.W.; Caranfa, M.J.; Holden, K.G.; Johnson,R.K.; Hecht, S.M.; Kingsbury, W.D. Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site. J. Biol. Chem. 1990, 265, 19287-19295.

    7. Ignor Chourpa; Abdel Beljebbar; Ganesh D.Sockalingum; Michel Manfait Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies? Biochimica et Biophyscia Acta (BBA ) -general subjects. 1997, 1334, 349-360.

    8. Priel, E.; Showalter, S. D.; Blair, D.G. Inhibition of human. immnnodeficiency virus (HIV-I) replication by non cytotoxic. doses of camptothecin, a topoisomerase I inhibitor. AIDS Res. Hum. Retrovir. 1991, 7, 65-72.

    9. Bodley, A.L.; Shapiro, T.A.; Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania. Proc. Natl. Acad. Sci. 1995, 92, 3726-3730.

    10. Jaxel, C.; Kohn, K. W.; Wani, M. C.; Wall, M. E. Structure activity study of the actions of camptothecin derivatives on mammalian topoisomerase 1: evidence for a specific receptor site and a relation to antitumor activity. Cancer Res. 1989, 49, 1465-1469.

  • Metrics
    No metrics available
Share - Bookmark